Skip to Content
VaccinesVaccines
  • Article
  • Open Access

31 October 2022

12 Pages

Severity and Mortality Predictors of COVID-19 Patients with Thrombotic Events-Evidence from the “COVID-One” Hospital in Albania

,
,
,
,
,
,
,
and
1
“Mother Teresa” University Hospital, Dibra Street, 1000 Tirana, Albania
2
Faculty of Medicine, Tirana University of Medicine, 1005 Tirana, Albania
3
School of Medicine, University of Crete, 70013 Heraklion, Greece
4
Department of Healthcare, Faculty of Health, University of Vlora, Kosova Street, 9401 Vlora, Albania

Abstract

COVID-19 vaccination leads to lower infection, morbidity, and mortality rates. However, COVID-19 infection leads to the development of coagulopathy-related manifestations in the form of both venous and arterial thromboembolism. This study aimed to assess the severity and mortality predictors of COVID-19 patients with thrombotic events in hospitalized patients in Albania. This is a retrospective study conducted in the “Mother Tereza” University Hospital of Tirana. Data were retrieved from the electronic databases of the hospital and only COVID-19 cases admitted to the infectious department during August–December 2020 were selected. Patients who, at admission, had a C-reactive protein (CRP) (mg/L) more than double and a D-dimer (ng/mL) more than triple according to international standards were included in the study. We performed univariate and multivariable logistic regression analysis, calculating unadjusted and adjusted odds ratios (ORs). A p-value < 0.05 was considered statistically significant. The study population included 60 hospitalized persons with a mean age of 64.4 years. Increased lactate dehydrogenase (LDH) (OR = 2.93; 95% CI = 0.82–10.42, p-value = 0.1) and increased creatine kinase (CK) (OR = 2.17; 95% CI = 0.63–7.46, p-value = 0.22) were related with increased probability of death. Moreover, a decreased number of lymphocytes was associated with increased mortality but with no statistical significance (OR = 0.40; 95% CI = 0.11–1.40, p-value = 0.15). The survival rate was higher for patients without comorbidities (p = 0.045). These results could serve as a baseline and as a reference for healthcare personnel who provides services to hospitalized patients with COVID-19. Further studies should take into consideration the vaccination of the population as well as including more hospitals and patients.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.